Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
12 Leser
Artikel bewerten:
(0)

Bayer Receives CancerCare Honor at 70th Anniversary Celebration Gala

WHIPPANY, N.J., April 23, 2014 /PRNewswire/ --Bayer HealthCare was honored by national non-profit CancerCare at their 70th Anniversary Celebration Gala in New York City on April 23. The gala honors individuals, companies and foundations that have made substantial contributions to improving the lives of people affected by cancer through their partnerships with CancerCare during the past 70 years. The award was presented by journalist and cancer advocate Katie Couric.

Bayer Receives CancerCare Award at 70th Anniversary Celebration Gala

Bayer has a long-standing commitment to CancerCare's mission of providing free support services to individuals affected by a cancer diagnosis. "Our partnership with Bayer continues as we announce the launch of the 'Pillow Talk Care Package' and 'Comfort Pillow' that will showcase the importance of psychosocial support in the care and treatment of cancer for patients, families and caregivers, and highlight the value of talking about a cancer diagnosis," said Brian Tomlinson, Chief Program and Communications Officer, CancerCare.

"At Bayer, the fight against cancer never stops," said Philip Blake, president, Bayer Corporation. "We're committed to continuing oncology research and we're proud to support CancerCare in their efforts to bring outstanding educational programs to help people whose lives have been affected by cancer."

About Oncology at Bayer
Bayer is committed to delivering Science for a Better Life by advancing a portfolio of innovative treatments.The oncology franchise at Bayer now includes three oncology products and several other compounds in various stages of clinical development. Together, these products reflect the company's approach to research, which prioritizes targets and pathways with the potential to impact the way that cancer is treated.

About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 18.9 billion (2013), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 56,000 employees (Dec. 31, 2013) and is represented in more than 100 countries. More information is available at www.healthcare.bayer.com.

About CancerCare
Founded in 1944, CancerCare® is the leading national organization providing free support services and information to help people manage the emotional, practical and financial challenges of cancer. CancerCare's comprehensive services include counseling and support groups over the phone, online and in-person, educational workshops, publications and financial and co-payment assistance. All CancerCare services are provided by professional oncology social workers. To learn more, visit www.cancercare.org.

Bayer® and the Bayer Cross® are registered trademarks of Bayer.

Intended for U.S. Media Only

Photo - http://photos.prnewswire.com/prnh/20140424/77909

SOURCE Bayer HealthCare

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.